Sanofi-Aventis joins YouTube revolution
February 18, 2009Sales and Marketing Sanofi-Aventis, diabetes
Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …
Genzyme says new plant approval is imminent
February 18, 2009Research and Development, Sales and Marketing Genzyme
Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …
Novartis and charity team up on AMD campaign
February 18, 2009Medical Communications, Sales and Marketing AMD, ophthalmology
Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …
Lilly to boost biotech stake in NeuroSearch deal
February 17, 2009Research and Development Denmark, Europe, NeuroSearch
Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …
Pharma needs fresh ideas from outside industry, says Barker
February 17, 2009Research and Development, Sales and Marketing ABPI, strategy
Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …
Positive results halt Avastin-Tarceva trial
February 16, 2009Sales and Marketing Cancer, Roche, avastin
A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …
GSK: renewing the HIV pipeline
February 16, 2009Research and Development GSK, HIV
GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …
Managers need training too
February 13, 2009Business Services management, recruitment, training
Most of us recognise that personal training and development is an essential requirement for successful career advancement, but for many …
Working Life: Kay Spiller
February 13, 2009Sales and Marketing Astellas Pharma Europe, marketing
How did you find your way into your role? This was really through what I would describe as the 'traditional' …
Bayer’s cardiovascular drug enters phase III
February 13, 2009Research and Development, Sales and Marketing Bayer, cv
Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …
Patient surveys to be a world first for NHS
February 13, 2009Sales and Marketing NHS, PROMs, hc
Patients who have a hip replacements or varicose vein surgery on the NHS will be among the first patients to …
Viehbacher sets out vision for diversified Sanofi-Aventis
February 11, 2009Sales and Marketing Sanofi
Sanofi-Aventis's new chief executive Chris Viehbacher has presented his vision to renew the company, which will include greater investment in …
Sanofi cleared to buy Zentiva
February 11, 2009Sales and Marketing Sanofi, generics
The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …
Novartis boasts strong sales for 2008
February 11, 2009Sales and Marketing Novartis
Novartis has weathered the financial downturn and delivered a strong performance for 2008. Overall group sales were boosted by 9% …
Health secretary to chair influential pharma group
February 11, 2009Sales and Marketing ABPI, reform
Health Secretary Alan Johnson has been appointed the chair of the Ministerial Industry Strategy Group (MISG) and business secretary Lord …
Industry braced for more mergers
February 11, 2009Sales and Marketing MA, restructure
In retrospect, Pfizer's move to buy another major pharmaceutical company was inevitable. Like its peers, Pfizer has been energetically restructuring …
Pfizer to disclose US clinical trial payments
February 10, 2009Medical Communications ethics
Pfizer has announced plans to disclose payments to healthcare professionals involved in clinical trials. The company will publicly declare all …
Roche hit by strong Swiss franc
February 10, 2009Sales and Marketing Roche
Roche delivered solid performance in 2008, but was unable to shake off the negative effect of a strong Swiss franc. …
Roche bid for Genentech turns ‘hostile’ – but stays friendly
February 10, 2009Sales and Marketing MA, Roche
Roche has launched a renewed bid to buy out Genentech, making a 'hostile' bid for the company by appealing directly …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
